Chronic Cancer Pain Management Program

Sponsored by Hamilton Health Sciences Corporation

About this trial

Last updated 6 months ago

Study ID

16187

Status

Completed

Type

Interventional

Phase

N/A

Placebo

Accepting

18+ Years

All Sexes

Trial Timing

Ended a year ago

What is this trial about?

The goal of this research study is to evaluate an online inter-professional pain management program for survivors of breast cancer. The main questions it aims to answer: 1. whether this treatment will help address the pain management concerns of patients, 2. whether it is feasible to offer this treatment in the future as multi-centre randomized controlled trial (RCT). Participants will be asked to attend a 6-week online pain management group sessions (1h/week). Participants will also be asked to fill out questionnaires before and after the program completion.

What are the participation requirements?

Inclusion Criteria

1. diagnosis of Stage 1-3 breast cancer;

2. had surgical excision at least 3 months ago;

3. completed neoadjuvant/adjuvant chemotherapy and/or radiation treatment at least 4 months ago;

4. within 5 years post active cancer treatment;

5. persistent pain within the last 3 months that is bothersome;

6. medical clearance to participate in the intervention

7. over 18 years of age;

8. verbal fluency in English;

9. have access to internet and technology to participate in the online program. Patients currently receiving adjuvant endocrine therapy or molecularly targeted therapies or who have completed these therapies within the last 5 years are eligible to participate.

Exclusion Criteria

* Participants will be excluded from the study if they:

1. demonstrate significant cognitive impairment as determined by the clinical judgment of the provider;

2. have a pre-existing non-cancer pain condition,

3. have severe emotional distress that interferes with group participation as determined by scores above 15 on the Patient Health Questionnaire-9.